802 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Bought by Luts & Greenleigh Group Inc.

Luts & Greenleigh Group Inc. bought a new stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 802 shares of the healthcare conglomerate’s stock, valued at approximately $408,000.

A number of other hedge funds have also modified their holdings of the business. Signature Resources Capital Management LLC raised its holdings in UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares during the last quarter. Saxony Capital Management LLC lifted its holdings in shares of UnitedHealth Group by 3.5% during the 2nd quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock worth $270,000 after acquiring an additional 18 shares during the period. GoalVest Advisory LLC boosted its holdings in shares of UnitedHealth Group by 0.6% in the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock valued at $1,591,000 after purchasing an additional 18 shares during the last quarter. Fiduciary Group LLC raised its position in shares of UnitedHealth Group by 0.5% in the 2nd quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock worth $1,882,000 after buying an additional 18 shares during the period. Finally, Continuum Advisory LLC raised its holdings in shares of UnitedHealth Group by 0.6% in the 2nd quarter. Continuum Advisory LLC now owns 3,410 shares of the healthcare conglomerate’s stock worth $1,737,000 after purchasing an additional 19 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

Shares of UNH opened at $589.16 on Tuesday. The company’s fifty day moving average price is $571.08 and its 200 day moving average price is $518.38. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $607.94. The company has a market capitalization of $542.25 billion, a PE ratio of 36.01, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. During the same quarter in the prior year, the business earned $6.14 earnings per share. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. As a group, analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.43%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Insiders Place Their Bets

In related news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on UNH. JPMorgan Chase & Co. raised their price objective on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research report on Thursday, May 30th. Robert W. Baird upped their price objective on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. Royal Bank of Canada boosted their price objective on shares of UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Morgan Stanley raised their price target on UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Finally, Barclays upped their price target on shares of UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. One investment analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $614.17.

Get Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.